Literature DB >> 26758862

The Immunologic Mechanisms of Eosinophilic Esophagitis.

David A Hill1,2, Jonathan M Spergel3,4.   

Abstract

Eosinophilic esophagitis (EoE) is a chronic allergic inflammatory disease that is triggered by food and/or environmental allergens and is characterized by a clinical and pathologic phenotype of progressive esophageal dysfunction due to tissue inflammation and fibrosis. EoE is suspected in patients with painful swallowing, among other symptoms, and is diagnosed by the presence of 15 or more eosinophils per high-power field in one or more of at least four esophageal biopsy specimens. The prevalence of EoE is increasing and has now reached rates similar to those of other chronic gastrointestinal disorders such as Crohn's disease. In recent years, our understanding of the immunologic mechanisms underlying this condition has grown considerably. Thanks to new genetic, molecular, cellular, animal, and translational studies, we can now postulate a detailed pathway by which exposure to allergens results in a complex and coordinated type 2 inflammatory cascade that, if not intervened upon, can result in pain on swallowing, esophageal strictures, and food impaction. Here, we review the most recent research in this field to synthesize and summarize our current understanding of this complex and important disease.

Entities:  

Keywords:  Eosinophilic esophagitis; Food allergy; Immunology; Inflammation

Mesh:

Substances:

Year:  2016        PMID: 26758862      PMCID: PMC4913464          DOI: 10.1007/s11882-015-0592-3

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  183 in total

1.  Long-term outcomes in pediatric-onset esophageal eosinophilia.

Authors:  Charles W DeBrosse; James P Franciosi; Eileen C King; Bridget K Buckmeier Butz; Allison B Greenberg; Margaret H Collins; J Pablo Abonia; Amal Assa'ad; Philip E Putnam; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2011-06-02       Impact factor: 10.793

2.  A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation.

Authors:  S P Hogan; A Mishra; E B Brandt; M P Royalty; S M Pope; N Zimmermann; P S Foster; M E Rothenberg
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

3.  Three brothers with dysphagia caused by eosinophilic esophagitis.

Authors:  Sonal M Patel; Kenneth R Falchuk
Journal:  Gastrointest Endosc       Date:  2005-01       Impact factor: 9.427

4.  Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients.

Authors:  Alex Straumann; Christian Bussmann; Markus Zuber; Simone Vannini; Hans-Uwe Simon; Alain Schoepfer
Journal:  Clin Gastroenterol Hepatol       Date:  2008-04-14       Impact factor: 11.382

Review 5.  Foxp3+ regulatory T cells: differentiation, specification, subphenotypes.

Authors:  Markus Feuerer; Jonathan A Hill; Diane Mathis; Christophe Benoist
Journal:  Nat Immunol       Date:  2009-07       Impact factor: 25.606

6.  Invariant natural killer T cells in children with eosinophilic esophagitis.

Authors:  S Jyonouchi; C L Smith; F Saretta; V Abraham; K R Ruymann; P Modayur-Chandramouleeswaran; M-L Wang; J M Spergel; A Cianferoni
Journal:  Clin Exp Allergy       Date:  2014-01       Impact factor: 5.018

7.  Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis.

Authors:  Carine Blanchard; Emily M Stucke; Karen Burwinkel; Julie M Caldwell; Margaret H Collins; Annette Ahrens; Bridget K Buckmeier; Sean C Jameson; Allison Greenberg; Ajay Kaul; James P Franciosi; Jonathan P Kushner; Lisa J Martin; Philip E Putnam; J Pablo Abonia; Suzanne I Wells; Marc E Rothenberg
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

Review 8.  Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563.

Authors: 
Journal:  Drugs R D       Date:  2008

9.  Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993-2013: a population-based study.

Authors:  B Giriens; P Yan; E Safroneeva; M Zwahlen; A Reinhard; A Nydegger; S Vavricka; C Sempoux; A Straumann; A M Schoepfer
Journal:  Allergy       Date:  2015-09-13       Impact factor: 13.146

10.  Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis.

Authors:  M Vicario; C Blanchard; K F Stringer; M H Collins; M K Mingler; A Ahrens; P E Putnam; J P Abonia; J Santos; M E Rothenberg
Journal:  Gut       Date:  2010-01       Impact factor: 23.059

View more
  19 in total

1.  Eosinophilic Esophagitis Is a Late Manifestation of the Allergic March.

Authors:  David A Hill; Robert W Grundmeier; Mark Ramos; Jonathan M Spergel
Journal:  J Allergy Clin Immunol Pract       Date:  2018-06-25

2.  The Prevalence of Eosinophilic Esophagitis in Pediatric Patients with IgE-Mediated Food Allergy.

Authors:  David A Hill; Jesse W Dudley; Jonathan M Spergel
Journal:  J Allergy Clin Immunol Pract       Date:  2016-12-30

Review 3.  Cell-by-cell deciphering of T cells in allergic inflammation.

Authors:  Ting Wen; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2019-11       Impact factor: 10.793

Review 4.  Human eosinophils and mast cells: Birds of a feather flock together.

Authors:  Piper A Robida; Pier Giorgio Puzzovio; Hadas Pahima; Francesca Levi-Schaffer; Bruce S Bochner
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

5.  Elevated expression of activated TH2 cells and milk-specific TH2 cells in milk-induced eosinophilic esophagitis.

Authors:  Antonella Cianferoni; Melanie A Ruffner; Ryan Guzek; Shaobo Guan; Terri Brown-Whitehorn; Amanda Muir; Jonathan M Spergel
Journal:  Ann Allergy Asthma Immunol       Date:  2017-12-28       Impact factor: 6.347

6.  Specific IgG4 antibodies to cow's milk proteins in pediatric patients with eosinophilic esophagitis.

Authors:  Alexander J Schuyler; Jeffrey M Wilson; Anubha Tripathi; Scott P Commins; Princess U Ogbogu; Patrice G Kruzsewski; Barrett H Barnes; Emily C McGowan; Lisa J Workman; Jonas Lidholm; Sheryl L Rifas-Shiman; Emily Oken; Diane R Gold; Thomas A E Platts-Mills; Elizabeth A Erwin
Journal:  J Allergy Clin Immunol       Date:  2018-04-18       Impact factor: 10.793

Review 7.  Genetics of eosinophilic esophagitis.

Authors:  L C Kottyan; M E Rothenberg
Journal:  Mucosal Immunol       Date:  2017-02-22       Impact factor: 7.313

8.  Is eosinophilic esophagitis a member of the atopic march?

Authors:  David A Hill; Jonathan M Spergel
Journal:  Ann Allergy Asthma Immunol       Date:  2018-02       Impact factor: 6.347

9.  Immunohistochemical expression of filaggrin is decreased in proton pump inhibitor non-responders compared with proton pump inhibitor responders of eosinophilic esophagitis.

Authors:  Nahoko Nagano; Asuka Araki; Noriyoshi Ishikawa; Mamiko Nagase; Kyoichi Adachi; Norihisa Ishimura; Shunji Ishihara; Yoshikazu Kinoshita; Riruke Maruyama
Journal:  Esophagus       Date:  2020-09-09       Impact factor: 4.230

10.  Peripheral markers of allergen-specific immune activation predict clinical allergy in eosinophilic esophagitis.

Authors:  Julianna Dilollo; Eric M Rodríguez-López; Leah Wilkey; Elizabeth K Martin; Jonathan M Spergel; David A Hill
Journal:  Allergy       Date:  2021-05-14       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.